Voluntary Recall of Daytrana Patch Issued

Shire has issued a voluntary recall of some Daytrana patches due to difficulty removing the liner.

Wednesday August 27th - 1:39pm

The pharmaceutical company Shire has issued a voluntary recall of some of their Daytrana skin patches. The patches administer medication to treat ADHD.

The recall is not safety related, and all Daytrana patches, including those recalled, can continue to be used.

Shire recalled the selected lots of Daytrana patches because the release liner was difficult to remove. Noven Pharmaceuticals, which makes the patches for Shire, has recently stated that they have identified the potential cause of this difficulty, and have also found a solution.

Shire has stated that it does not anticipate a shortage of the medication due to the recall.

FDA is warning that permanent loss of skin color may occur with use of the Daytrana patch (methylphenidate transdermal system) for Attention Deficit Hyperactivity Disorder (ADHD). FDA added a new warning to the drug label to describe this skin condition, which is known as chemical leukoderma. See the FDA Drug Safety Communication for more information.

Copyright © 1998 - 2015 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 108 West 39th Street, Suite 805, New York, NY 10018